Toru Kondo

2.3k total citations
141 papers, 888 citations indexed

About

Toru Kondo is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Biomedical Engineering. According to data from OpenAlex, Toru Kondo has authored 141 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Cardiology and Cardiovascular Medicine, 37 papers in Surgery and 23 papers in Biomedical Engineering. Recurrent topics in Toru Kondo's work include Cardiovascular Function and Risk Factors (46 papers), Heart Failure Treatment and Management (44 papers) and Mechanical Circulatory Support Devices (20 papers). Toru Kondo is often cited by papers focused on Cardiovascular Function and Risk Factors (46 papers), Heart Failure Treatment and Management (44 papers) and Mechanical Circulatory Support Devices (20 papers). Toru Kondo collaborates with scholars based in Japan, United Kingdom and United States. Toru Kondo's co-authors include Takahiro Okumura, Toyoaki Murohara, Hiroaki Hiraiwa, John J.V. McMurray, Ryota Morimoto, Pardeep S. Jhund, S. Kazama, Tasuku Kuwayama, Scott D. Solomon and Hideo Oishi and has published in prestigious journals such as Circulation, Nature Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Toru Kondo

123 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toru Kondo Japan	15	473	169	100	99	96	141	888
Mandeep Singh India	11	195 0.4×	228 1.3×	86 0.9×	77 0.8×	63 0.7×	46	668
Makoto Hiki Japan	16	231 0.5×	201 1.2×	85 0.8×	49 0.5×	17 0.2×	78	771
Yongyi Bai China	16	511 1.1×	120 0.7×	21 0.2×	119 1.2×	23 0.2×	54	930
Chao Zheng China	8	311 0.7×	161 1.0×	165 1.6×	160 1.6×	16 0.2×	11	2.0k
Gunnar Nordin Sweden	18	253 0.5×	222 1.3×	49 0.5×	146 1.5×	21 0.2×	63	1.5k
Ju‐Yi Chen Taiwan	19	973 2.1×	266 1.6×	132 1.3×	241 2.4×	37 0.4×	107	1.5k
Bonizella Biagioli Italy	17	429 0.9×	420 2.5×	147 1.5×	108 1.1×	24 0.3×	42	868
Francisco J. Pastor‐Pérez Spain	16	558 1.2×	203 1.2×	78 0.8×	98 1.0×	8 0.1×	36	886
Peter Dunselman Sweden	9	452 1.0×	256 1.5×	22 0.2×	61 0.6×	34 0.4×	13	679
Shari Targum United States	11	1.3k 2.7×	368 2.2×	127 1.3×	242 2.4×	14 0.1×	13	1.7k

Countries citing papers authored by Toru Kondo

Since Specialization

Citations

This map shows the geographic impact of Toru Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Kondo more than expected).

Fields of papers citing papers by Toru Kondo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Kondo. The network helps show where Toru Kondo may publish in the future.

Co-authorship network of co-authors of Toru Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Kondo. A scholar is included among the top collaborators of Toru Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Kondo. Toru Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kondo, Toru, Pardeep S. Jhund, Inder S. Anand, et al.. (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF. JACC Heart Failure. 13(6). 927–939. 2 indexed citations

Morimoto, Ryota, S. Kazama, Hiroaki Hiraiwa, et al.. (2025). Cancer Therapy-Related Cardiac Dysfunction in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated With Trastuzumab and Pertuzumab. Circulation Reports. 7(9). 800–808. 1 indexed citations

Kondo, Toru, Pooja Dewan, Akshay S. Desai, et al.. (2025). Impact of Multimorbidity on Mortality in Heart Failure With Mildly Reduced and Preserved Ejection Fraction. Circulation Heart Failure. 18(3). e011598–e011598. 2 indexed citations

Uemura, Yusuke, Toru Kondo, S. Kazama, et al.. (2025). Clinical impact of pulmonary artery pulsatility index in patients with atrial fibrillation and heart failure. Acta cardiologica. Supplementum. 80(6). 614–622.

Imaizumi, Takahiro, Manabu Hishida, Yoshihiro Nakamura, et al.. (2025). Longitudinal impact of extended-hours hemodialysis with a liberalized diet on nutritional status and survival outcomes: findings from the LIBERTY cohort. Clinical and Experimental Nephrology. 29(6). 818–830. 1 indexed citations

Kondo, Toru, Ryota Morimoto, S. Kazama, et al.. (2025). Direct Visualization of External Outflow Graft Obstruction in Durable Left Ventricular Assist Device Using Transthoracic Echocardiography. ASAIO Journal. 71(12). e231–e234. 1 indexed citations

Imaizumi, Takahiro, et al.. (2025). Ultrafiltration rate and mortality in patients undergoing extended-hours haemodialysis. Clinical Kidney Journal. 18(10). sfaf287–sfaf287.

Mouri, Atsuto, Ryo Ko, Tomonori Makiguchi, et al.. (2024). A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A. ESMO Open. 9(10). 103939–103939. 1 indexed citations

Kondo, Toru, Alasdair Henderson, Kieran F. Docherty, et al.. (2024). Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF?. Journal of the American College of Cardiology. 84(22). 2233–2240. 7 indexed citations

10.

Yang, Mingming, Paolo Tolomeo, Toru Kondo, et al.. (2024). Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM‐HF and PARAGON‐HF. Journal of the American Heart Association. 14(1). e037782–e037782. 4 indexed citations

11.

Araki, Takashi, Toru Kondo, Takahiro Imaizumi, et al.. (2023). Relationship between the volume of cases and in-hospital mortality in patients with cardiogenic shock receiving short-term mechanical circulatory support. American Heart Journal. 261. 109–123. 7 indexed citations

12.

Yang, Mingming, Toru Kondo, Carly Adamson, et al.. (2023). Knowledge About Self-Efficacy and Outcomes in Patients with Heart Failure and Reduced Ejection Fraction. European Journal of Heart Failure. 25(10). 1831–1839. 3 indexed citations

13.

Tolomeo, Paolo, Jawad H. Butt, Toru Kondo, et al.. (2023). Importance of cystatin C in estimating glomerular filtration rate: the PARADIGM-HF trial. European Heart Journal. 44(24). 2202–2212. 14 indexed citations

14.

Imaizumi, Takahiro, et al.. (2023). Number of calcified aortic valve leaflets: natural history and prognostic value in patients undergoing haemodialysis. European Heart Journal - Cardiovascular Imaging. 24(7). 909–920. 3 indexed citations

15.

Kondo, Toru, Pooja Dewan, Inder S. Anand, et al.. (2023). Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?. Circulation. 148(9). 732–749. 18 indexed citations

16.

Kondo, Toru, Karola Jering, Pardeep S. Jhund, et al.. (2023). Predicting Stroke in Heart Failure and Preserved Ejection Fraction Without Atrial Fibrillation. Circulation Heart Failure. 16(7). e010377–e010377. 3 indexed citations

17.

Kondo, Toru, Karola Jering, C. Jan Willem Borleffs, et al.. (2023). Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation. 147(14). 1067–1078. 5 indexed citations

18.

Kondo, Toru, Jawad H. Butt, James P. Curtain, et al.. (2023). Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Circulation Heart Failure. 16(12). e010898–e010898. 3 indexed citations

19.

Yang, Mingming, Toru Kondo, Carly Adamson, et al.. (2023). Impact of Comorbidities on Health Status Measured Using the Kansas City Cardiomyopathy Questionnaire in Patients with Heart Failure with Reduced and Preserved Ejection Fraction. European Journal of Heart Failure. 25(9). 1606–1618. 16 indexed citations

20.

Hishida, Manabu, et al.. (2021). All-cause and cardiovascular mortality in patients undergoing hemodialysis with aortic sclerosis and mild-to-moderate aortic stenosis: A cohort study. Atherosclerosis. 331. 12–19. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact